Enovis ENOV
NYSE ENOV
$18.60 -0.43 (-2.26%)
As of: Sep 10, 2026 · 12:40 PM EDT

Enovis (ENOV) Change in Acquisitions & Divestments (2018)

Enovis' (ENOV) quarterly Change in Acquisitions & Divestments came in at $139.5 million in Q2 2018.

Analysis

Enovis (ENOV) Change in Acquisitions & Divestments (2018) Analysis & Trends

Enovis (ENOV) has reported Change in Acquisitions & Divestments for 1 consecutive years, with $139.5 million the latest figure, recorded in Q2 2018.

  • On a quarterly basis, Change in Acquisitions & Divestments changed N/A year-over-year to $139.5 million in Q2 2018; TTM through Dec 2019 was $139.5 million, a 0.0% change from a year earlier, with the FY2018 full-year figure at $139.5 million, changed N/A from the prior year.
  • Change in Acquisitions & Divestments was $139.5 million for Q2 2018 at Enovis.
  • Over five years, Change in Acquisitions & Divestments peaked at $139.5 million in Q2 2018 and troughed at $139.5 million in Q2 2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 181.19 Bn 175.58 Bn 7.27 Bn
2 Intuitive Surgical 127.77 Bn 122.55 Bn 1.96 Bn
3 Medtronic 117.13 Bn 108.31 Bn 6.34 Bn
4 Stryker 104.67 Bn 101.20 Bn 4.50 Bn
5 Boston Scientific 64.48 Bn 63.94 Bn 3.85 Bn
6 Edwards Lifesciences 49.97 Bn 45.72 Bn 1.35 Bn
7 Alcon 33.06 Bn 31.61 Bn 1.68 Bn
8 Dexcom 32.37 Bn 30.43 Bn 830.00 Mn
9 Steris 20.76 Bn 20.28 Bn 684.20 Mn
10 Enovis 1.07 Bn 1.06 Bn 359.25 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 29, 2018 139.50 Mn